Chemical Works of Gedeon Richter Plc (RGEDF)
41.20
+0.76
(+1.87%)
USD |
OTCM |
Oct 26, 16:00
Chemical Works of Gedeon Richter Price : 41.20 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 41.43 | 41.43 | 40.64 | 41.20 | 240.00 |
| Oct 23, 2026 | 39.61 | 40.58 | 39.61 | 40.44 | 184.00 |
| Oct 22, 2026 | 39.42 | 39.42 | 39.42 | 39.42 | 0.000 |
| Oct 21, 2026 | 39.42 | 39.42 | 39.42 | 39.42 | 6.000 |
| Oct 20, 2026 | 40.24 | 40.24 | 37.63 | 39.83 | 948.00 |
| Oct 19, 2026 | 39.59 | 39.63 | 39.59 | 39.63 | 7.000 |
| Oct 16, 2026 | 39.22 | 39.22 | 39.22 | 39.22 | 3.000 |
| Oct 15, 2026 | 40.12 | 40.26 | 37.45 | 38.63 | 1222.00 |
| Oct 14, 2026 | 38.93 | 38.93 | 37.99 | 37.99 | 15.00 |
| Oct 13, 2026 | 38.51 | 38.55 | 38.51 | 38.55 | 34.00 |
| Oct 12, 2026 | 37.26 | 38.37 | 37.26 | 38.37 | 119.00 |
| Oct 09, 2026 | 35.75 | 38.12 | 35.75 | 37.12 | 174.00 |
| Oct 08, 2026 | 37.02 | 37.94 | 35.75 | 35.75 | 71.00 |
| Oct 07, 2026 | 38.46 | 38.46 | 36.00 | 36.00 | 111.00 |
| Oct 06, 2026 | 37.49 | 38.55 | 37.49 | 38.55 | 8752.00 |
| Oct 05, 2026 | 37.84 | 37.97 | 37.84 | 37.93 | 17.00 |
| Oct 02, 2026 | 38.40 | 38.40 | 38.36 | 38.36 | 17.00 |
| Oct 01, 2026 | 38.41 | 38.41 | 38.41 | 38.41 | 28.00 |
| Sep 30, 2026 | 39.14 | 39.14 | 39.14 | 39.14 | 32.00 |
| Sep 29, 2026 | 37.58 | 38.72 | 37.58 | 38.72 | 108.00 |
| Sep 28, 2026 | 38.80 | 38.87 | 38.80 | 38.87 | 72.00 |
| Sep 25, 2026 | 38.96 | 39.54 | 38.49 | 39.54 | 124.00 |
| Sep 24, 2026 | 39.69 | 39.69 | 38.75 | 38.75 | 84.00 |
| Sep 23, 2026 | 40.95 | 40.95 | 38.92 | 38.92 | 20.00 |
| Sep 22, 2026 | 40.91 | 40.99 | 40.91 | 40.99 | 105.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 170.08 |
| ANI Pharmaceuticals, Inc. | 70.10 |
| Corcept Therapeutics, Inc. | 87.71 |
| Veru, Inc. | 2.28 |
| Avadel Pharmaceuticals Plc | 21.64 |
Price Related Metrics
| PE Ratio | 11.45 |
| PS Ratio | 2.660 |
| PEG Ratio | 1.055 |
| Price to Book Value | 1.727 |
| Price to Free Cash Flow | 9.329 |
| Earnings Yield | 8.74% |
| Market Cap | 7.543B |
| PEGY Ratio | 0.7129 |
| Operating PE Ratio | 7.511 |
| Normalized PE Ratio | 11.44 |